Millennium Management »

Nektar Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $33M 571k 56.90
2025-06-30 $19M 728k 25.84

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Meta Platforms Cl A (META)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom Call Option (AVGO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Financial Call Option (XLF)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Millennium Management

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics